Shineway Pharm Schedules 18 September 2026 Board Meeting to Review Special Interim Dividend
Bulletin Express
Sep 08
China Shineway Pharmaceutical Group Limited (Shineway Pharm) has announced that its board of directors will convene on 18 September 2026 to consider declaring a special interim dividend for shareholders.\n\nThe meeting will evaluate the amount and timing of the prospective distribution. No further financial details were disclosed in the notice.\n\nAs of the announcement date, the board comprises three executive directors—Li Zhenjiang, Xin Yunxia and Li Huimin—one non-executive director, Zhou Wencheng, and three independent non-executive directors, Liu Shun Fai, Yew Yat On and Wang Guihua.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.